Araştırma Makalesi


DOI :10.26650/IUITFD.2021.806433   IUP :10.26650/IUITFD.2021.806433    Tam Metin (PDF)

İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ

Özge KabaMehpare Sarı YanartaşSelda Hançerli TörünKamala AlakbarovaZuhal BayramoğluMustafa ÖnelSevim MeşeAli AğaçfidanAyper Somer

Amaç: Beklenmedik bir anda tüm dünyayı etkileyen SARS-CoV-2 virüsü milyonlarca insanı enfekte etmeye ve yüzbinlerce insanın da ölüme neden olmaya devam etmektedir. Pediyatrik yaş grubuna dair görüş birliği henüz sağlanamamıştır. Bu nedenle merkezimize ait pediyatrik grup deneyiminin paylaşılması amaçlanmıştır. Gereç ve Yöntem: Pandemi ilanından sonra merkezimize COVID-19 hastalığı şüphesiyle başvuran 1076 çocuk olgu ele alındı. SARS-CoV-2 polimeraz zincir reaksiyon testinde pozitif olan 85 çocuk, epidemiyolojik, klinik, laboratuvar ve görüntüleme verileri ile retrospektif olarak değerlendirildi. Bulgular: Hastaların yarısı erkek ve yaklaşık yarısı 60-179 ay arasındaydı. Hastaların %80’inde ev içi temas/maruziyet mevcuttu. En sık şikayetler sırasıyla %51,8 ve %47,1 oranlarıyla öksürük ve ateşti. Hastaların %72,9’unda daha hafif klinik tablo ve sadece %2,4’ünde kritik hastalık vardı. En çarpıcı laboratuvar bulgusu lenfopeniydi. Görüntüleme sonuçları, anormal toraks BT oranının %10,6 olduğunu gösterdi. Hastaların %80’ine evde izolasyon uygulandı. Hastanede yatan hastaların sadece %4,7’sinde çeşitli spesifik tedaviler uygulandı. Hidroksiklorokin, intravenöz immünglobulin ve tosilizumab alan bu hastalardan biri öldü. Mortalite oranı %1,5 idi. Sonuç: Güvenilir tanısal testlerin ve çocuklar için uygun spesifik antiviral tedavilerin yokluğunda, COVID-19 enfeksiyonunu daha iyi anlamak ve yönetmek için daha virolojik, epidemiyolojik, klinik, laboratuvar ve görüntüleme çalışmalarına ihtiyaç olduğu fikrine varıldı. 

Anahtar Kelimeler: COVID-19çocukyönetimtedavi
DOI :10.26650/IUITFD.2021.806433   IUP :10.26650/IUITFD.2021.806433    Tam Metin (PDF)

EXPERIENCE IN CHILDREN IN THE COVID-19 PANDEMIC OF A TERTIARY CENTER, IN ISTANBUL

Özge KabaMehpare Sarı YanartaşSelda Hançerli TörünKamala AlakbarovaZuhal BayramoğluMustafa ÖnelSevim MeşeAli AğaçfidanAyper Somer

Objective: The SARS-CoV-2 virus, which unexpectedly has affected the whole world, continues to infect millions of people and causes the death of hundreds of thousands of people. There has been no consensus on the pediatric age group yet. For this reason, it was aimed to share the pediatric group experience of our center. Material and Method: After the pandemic announcement, 1076 pediatric cases admitted to our center with suspected COVID-19 disease were discussed. Eighty-five children who were positive in the SARS-CoV-2 polymerase chain reaction test, were evaluated retrospectively with epidemiological, clinical, laboratory and imaging data. Results: Half of the patients were male and about half of them were between 60-179 months. The household contact/exposure was 80% of the patients. The most common complaints were cough and fever, with the rates of 51.8% and 47.1%, respectively. There was a milder clinic 72.9% of patients and critical illness only 2.4% of the patients. The most striking laboratory finding was lymphopenia. Imaging results showed that abnormal thorax CT rate was 10.6%. Isolation at home was administered on 80% of the patients. Various specific treatments were used only in 4.7% of the hospitalized patients. One of these patients who received hydroxychloroquine, intravenous immunglobuline and tocilizumab died. The mortality rate was 1.5%. Conclusion: In the absence of reliable diagnostic tests and specific antiviral treatments appropriate for children, it was concluded that we need more virological, epidemiological, clinical, laboratory and imaging studies to better understand and manage COVID-19 infection.

Anahtar Kelimeler: COVID-19childmanagementtreatment

PDF Görünüm

Referanslar

  • 1. World Health Organization (WHO). Emergencies. Diseases. Coronavirus disease (COVID-19). Situation reports. Situation report-51. Available at https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 Accessed on 5 Oct, 2020 google scholar
  • 2. World Health Organization (WHO). Emergencies. Diseases. Coronavirus disease 2019. Available at https://www.who.int/ emergencies/diseases/novel-coronavirus-2019. Accessed on 5 Oct, 2020. google scholar
  • 3. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, Villamizar-Pena R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623. [CrossRef] google scholar
  • 4. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020;109(6):1088-1095. [CrossRef] google scholar
  • 5. Halk Sağlığı Genel Müdürlüğü, COVID-19 Bilgilendirme Sayfası, COVID-19 Rehberi Çocuk Hasta Yönetimi ve Tedavi. Available at https://covid19.saglik.gov.tr/Eklenti/38596/0/ covid-19rehbericocukhastayonetimivetedavipdf.pdf Accessed on 5 Oct, 2020. google scholar
  • 6. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics 2020;145(6):e20200702. [CrossRef] google scholar
  • 7. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARSCoV-2 infection in children 2020. N Engl J Med 2020;382(17):1663-5. [CrossRef] google scholar
  • 8. Tezer H, Bedir Demirdağ T. Novel coronavirus disease (COVID-19) in children. Turk J Med Sci 2020;50(SI-1):592-603. Published 2020 Apr 21. [CrossRef] google scholar
  • 9. Parri N, Lenge M, Buonsenso D; Coronavirus Infection in Pediatric Emergency Departments (CONFIDENCE) Research Group. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med 2020;383(2):187-90. [CrossRef] google scholar
  • 10. Tagarro A, Epalza C, Santos M, Sanz-Santaeufemia FJ, Otheo E, Moraleda C, et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA Pediatr 2020 Apr 8:e201346. [CrossRef] google scholar
  • 11. Centers for Disease Control and Prevention, Coronavirus Disease (COVID-19), Cases&Data, MMWR COVID-19 Reports, Changing Age Distribution of the COVID-19 Pandemic—United States, May-August 2020. Available at https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm69 39e1-H.pdf. Accessed on 5 Oct, 2020. google scholar
  • 12. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-42. [CrossRef] google scholar
  • 13. Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med 2015;13:210. [CrossRef] google scholar
  • 14. Zhang B, Liu S, Zhang J, Xiao J, Zhu S, Dong Y, et al. Children hospitalized for coronavirus disease 2019 (COVID-19): A multicenter retrospective descriptive study. J Infect 2020;81(2):e74-5. [CrossRef] google scholar
  • 15. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-62. [CrossRef] google scholar
  • 16. CDC COVID-19 Response Team. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep 2020;69(13):382-386. [CrossRef] google scholar
  • 17. Deza Leon MP, Redzepi A, McGrath E, Abdel-Haq N, Shawaqfeh A, Sethuraman U, et al. COVID-19 Associated Pediatric Multi-System Inflammatory Syndrome. J Pediatric Infect Dis Soc 2020;9(3):407-8. [CrossRef] google scholar
  • 18. Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: A systematic review and meta-analysis. J Formos Med Assoc 2020;119(5):982-9. [CrossRef] google scholar
  • 19. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382(18):1708-1720. [CrossRef] google scholar
  • 20. Ma H, Hu J, Tian J, Zhou X, Li H, Laws MT, et al. A single-center, retrospective study of COVID-19 features in children: a descriptive investigation. BMC Med 2020;18(1):123. Published 2020 May 6. [CrossRef] google scholar
  • 21. Steinberger S, Lin B, Bernheim A, Chung M, Gao Y, Xie Z, et al. CT Features of Coronavirus Disease (COVID-19) in 30 Pediatric Patients. AJR Am J Roentgenol 2020;215(6):1303-11. [CrossRef] google scholar
  • 22. Chen A, Huang J, Liao Y, Liu Z, Chen D, Yang C, et al. Differences in clinical and imaging presentation of pediatric patients witf COVID-19 in comparison with adults. Radiol Cardiothrac Imaging 2020;2(2):e200117. [CrossRef] google scholar
  • 23. Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr 2020;16(3):240-6. [CrossRef] google scholar
  • 24. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr 2020;174(9):868-73. [CrossRef] google scholar
  • 25. Chiotos K, Hayes M, Kimberlin DW, Jones SB, James SH, Pinninti SG, et al. Multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2. J Pediatric Infect Dis Soc 2020;9(6):701-15. [CrossRef] google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Kaba, Ö., Sarı Yanartaş, M., Hançerli Törün, S., Alakbarova, K., Bayramoğlu, Z., Önel, M., Meşe, S., Ağaçfidan, A., & Somer, A. (2021). İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ. İstanbul Tıp Fakültesi Dergisi, 84(3), 293-300. https://doi.org/10.26650/IUITFD.2021.806433


AMA

Kaba Ö, Sarı Yanartaş M, Hançerli Törün S, Alakbarova K, Bayramoğlu Z, Önel M, Meşe S, Ağaçfidan A, Somer A. İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ. İstanbul Tıp Fakültesi Dergisi. 2021;84(3):293-300. https://doi.org/10.26650/IUITFD.2021.806433


ABNT

Kaba, Ö.; Sarı Yanartaş, M.; Hançerli Törün, S.; Alakbarova, K.; Bayramoğlu, Z.; Önel, M.; Meşe, S.; Ağaçfidan, A.; Somer, A. İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ. İstanbul Tıp Fakültesi Dergisi, [Publisher Location], v. 84, n. 3, p. 293-300, 2021.


Chicago: Author-Date Style

Kaba, Özge, and Mehpare Sarı Yanartaş and Selda Hançerli Törün and Kamala Alakbarova and Zuhal Bayramoğlu and Mustafa Önel and Sevim Meşe and Ali Ağaçfidan and Ayper Somer. 2021. “İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ.” İstanbul Tıp Fakültesi Dergisi 84, no. 3: 293-300. https://doi.org/10.26650/IUITFD.2021.806433


Chicago: Humanities Style

Kaba, Özge, and Mehpare Sarı Yanartaş and Selda Hançerli Törün and Kamala Alakbarova and Zuhal Bayramoğlu and Mustafa Önel and Sevim Meşe and Ali Ağaçfidan and Ayper Somer. İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ.” İstanbul Tıp Fakültesi Dergisi 84, no. 3 (Dec. 2024): 293-300. https://doi.org/10.26650/IUITFD.2021.806433


Harvard: Australian Style

Kaba, Ö & Sarı Yanartaş, M & Hançerli Törün, S & Alakbarova, K & Bayramoğlu, Z & Önel, M & Meşe, S & Ağaçfidan, A & Somer, A 2021, 'İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ', İstanbul Tıp Fakültesi Dergisi, vol. 84, no. 3, pp. 293-300, viewed 23 Dec. 2024, https://doi.org/10.26650/IUITFD.2021.806433


Harvard: Author-Date Style

Kaba, Ö. and Sarı Yanartaş, M. and Hançerli Törün, S. and Alakbarova, K. and Bayramoğlu, Z. and Önel, M. and Meşe, S. and Ağaçfidan, A. and Somer, A. (2021) ‘İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ’, İstanbul Tıp Fakültesi Dergisi, 84(3), pp. 293-300. https://doi.org/10.26650/IUITFD.2021.806433 (23 Dec. 2024).


MLA

Kaba, Özge, and Mehpare Sarı Yanartaş and Selda Hançerli Törün and Kamala Alakbarova and Zuhal Bayramoğlu and Mustafa Önel and Sevim Meşe and Ali Ağaçfidan and Ayper Somer. İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ.” İstanbul Tıp Fakültesi Dergisi, vol. 84, no. 3, 2021, pp. 293-300. [Database Container], https://doi.org/10.26650/IUITFD.2021.806433


Vancouver

Kaba Ö, Sarı Yanartaş M, Hançerli Törün S, Alakbarova K, Bayramoğlu Z, Önel M, Meşe S, Ağaçfidan A, Somer A. İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ. İstanbul Tıp Fakültesi Dergisi [Internet]. 23 Dec. 2024 [cited 23 Dec. 2024];84(3):293-300. Available from: https://doi.org/10.26650/IUITFD.2021.806433 doi: 10.26650/IUITFD.2021.806433


ISNAD

Kaba, Özge - Sarı Yanartaş, Mehpare - Hançerli Törün, Selda - Alakbarova, Kamala - Bayramoğlu, Zuhal - Önel, Mustafa - Meşe, Sevim - Ağaçfidan, Ali - Somer, Ayper. İSTANBUL’DA ÜÇÜNCÜ BASAMAK BİR MERKEZİN COVİD-19 PANDEMİSİNDE ÇOCUKLARDAKİ DENEYİMİ”. İstanbul Tıp Fakültesi Dergisi 84/3 (Dec. 2024): 293-300. https://doi.org/10.26650/IUITFD.2021.806433



ZAMAN ÇİZELGESİ


Gönderim06.10.2020
Kabul09.04.2021
Çevrimiçi Yayınlanma29.06.2021

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.